[96a5a0]: / output / allTrials / identified / NCT01831076_identified.json

Download this file

493 lines (493 with data), 21.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
{
"info": {
"nct_id": "NCT01831076",
"official_title": "Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors. A Phase II Study to Identify Molecular Predictors for Hormone Responsiveness and/or Resistance.",
"inclusion_criteria": "* Histologically or cytologically confirmed breast cancer\n* ER positive (+)\n* Primary tumor 2-4 regional lymph nodes 0-2 (T2-4N0-2); patients may have metastatic disease, provided local-regional surgery is clinically indicated\n* Clinical stage II/III\n* Postmenopausal- defined as having had a previous bilateral oophorectomy or, for women with no prior hysterectomy, the absence of spontaneous menstrual cycles for more than 1 year\n* Newly diagnosed\n* Patients with prior non-breast malignancies are eligible if they have been disease free for >= 5 years before study entry; patients with squamous or basal cell carcinoma of the skin that has been effectively treated, carcinoma in situ of the cervix that has been treated by surgery only, or lobular carcinoma in situ (LCIS) of the ipsilateral or contralateral breast that has been treated by surgery only are eligible, even if the cancer was diagnosed within 5 years before randomization\n* Serum creatinine =< 1.5 x institutional upper limit of normal (ULN)\n* Hemoglobin within normal limits for institution\n* Absolute granulocyte count >= 1500\n* Platelet count >= 100,000\n* Serum glutamic oxaloacetic transaminase (SGOT), aspartate aminotransferase (AST) or serum glutamate pyruvate transaminase (SGPT), alanine aminotransferase (ALT) =< 2.5 x ULN\n* Total bilirubin < 2 x ULN for institution\n* Alkaline phosphatase < 2 x the ULN\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 50 Years",
"exclusion_criteria": "* Completely resected\n* Prior hormone or chemotherapy\n* Unable to take oral medication\n* Patients who have nonmalignant systemic disease (cardiovascular, renal, hepatic, etc.) that would preclude their being subjected to protocol therapy",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically or cytologically confirmed breast cancer",
"criterions": [
{
"exact_snippets": "Histologically or cytologically confirmed breast cancer",
"criterion": "breast cancer",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
}
]
},
{
"line": "* ER positive (+)",
"criterions": [
{
"exact_snippets": "ER positive (+)",
"criterion": "ER status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "positive"
}
]
}
]
},
{
"line": "* Primary tumor 2-4 regional lymph nodes 0-2 (T2-4N0-2); patients may have metastatic disease, provided local-regional surgery is clinically indicated",
"criterions": [
{
"exact_snippets": "Primary tumor 2-4",
"criterion": "primary tumor",
"requirements": [
{
"requirement_type": "stage",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2,
"unit": "N/A"
},
{
"operator": "<=",
"value": 4,
"unit": "N/A"
}
]
}
}
]
},
{
"exact_snippets": "regional lymph nodes 0-2",
"criterion": "regional lymph nodes",
"requirements": [
{
"requirement_type": "stage",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
},
{
"exact_snippets": "patients may have metastatic disease",
"criterion": "metastatic disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "local-regional surgery is clinically indicated",
"criterion": "local-regional surgery",
"requirements": [
{
"requirement_type": "indication",
"expected_value": "clinically indicated"
}
]
}
]
},
{
"line": "* Clinical stage II/III",
"criterions": [
{
"exact_snippets": "Clinical stage II/III",
"criterion": "clinical stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"II",
"III"
]
}
]
}
]
},
{
"line": "* Postmenopausal- defined as having had a previous bilateral oophorectomy or, for women with no prior hysterectomy, the absence of spontaneous menstrual cycles for more than 1 year",
"criterions": [
{
"exact_snippets": "Postmenopausal- defined as having had a previous bilateral oophorectomy",
"criterion": "postmenopausal status",
"requirements": [
{
"requirement_type": "definition",
"expected_value": "previous bilateral oophorectomy"
}
]
},
{
"exact_snippets": "Postmenopausal- defined as ... for women with no prior hysterectomy, the absence of spontaneous menstrual cycles for more than 1 year",
"criterion": "postmenopausal status",
"requirements": [
{
"requirement_type": "definition",
"expected_value": "absence of spontaneous menstrual cycles for more than 1 year"
}
]
}
]
},
{
"line": "* Newly diagnosed",
"criterions": [
{
"exact_snippets": "Newly diagnosed",
"criterion": "diagnosis status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "newly diagnosed"
}
]
}
]
},
{
"line": "* Patients with prior non-breast malignancies are eligible if they have been disease free for >= 5 years before study entry; patients with squamous or basal cell carcinoma of the skin that has been effectively treated, carcinoma in situ of the cervix that has been treated by surgery only, or lobular carcinoma in situ (LCIS) of the ipsilateral or contralateral breast that has been treated by surgery only are eligible, even if the cancer was diagnosed within 5 years before randomization",
"criterions": [
{
"exact_snippets": "prior non-breast malignancies",
"criterion": "prior non-breast malignancies",
"requirements": [
{
"requirement_type": "disease-free duration",
"expected_value": {
"operator": ">=",
"value": 5,
"unit": "years"
}
}
]
},
{
"exact_snippets": "squamous or basal cell carcinoma of the skin that has been effectively treated",
"criterion": "squamous or basal cell carcinoma of the skin",
"requirements": [
{
"requirement_type": "treatment effectiveness",
"expected_value": "effectively treated"
}
]
},
{
"exact_snippets": "carcinoma in situ of the cervix that has been treated by surgery only",
"criterion": "carcinoma in situ of the cervix",
"requirements": [
{
"requirement_type": "treatment type",
"expected_value": "surgery only"
}
]
},
{
"exact_snippets": "lobular carcinoma in situ (LCIS) of the ipsilateral or contralateral breast that has been treated by surgery only",
"criterion": "lobular carcinoma in situ (LCIS) of the breast",
"requirements": [
{
"requirement_type": "treatment type",
"expected_value": "surgery only"
}
]
}
]
},
{
"line": "* Serum creatinine =< 1.5 x institutional upper limit of normal (ULN)",
"criterions": [
{
"exact_snippets": "Serum creatinine =< 1.5 x institutional upper limit of normal (ULN)",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x institutional upper limit of normal (ULN)"
}
}
]
}
]
},
{
"line": "* Hemoglobin within normal limits for institution",
"criterions": [
{
"exact_snippets": "Hemoglobin within normal limits for institution",
"criterion": "hemoglobin",
"requirements": [
{
"requirement_type": "range",
"expected_value": "within normal limits for institution"
}
]
}
]
},
{
"line": "* Absolute granulocyte count >= 1500",
"criterions": [
{
"exact_snippets": "Absolute granulocyte count >= 1500",
"criterion": "absolute granulocyte count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Platelet count >= 100,000",
"criterions": [
{
"exact_snippets": "Platelet count >= 100,000",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": ""
}
}
]
}
]
},
{
"line": "* Serum glutamic oxaloacetic transaminase (SGOT), aspartate aminotransferase (AST) or serum glutamate pyruvate transaminase (SGPT), alanine aminotransferase (ALT) =< 2.5 x ULN",
"criterions": [
{
"exact_snippets": "Serum glutamic oxaloacetic transaminase (SGOT), aspartate aminotransferase (AST) ... =< 2.5 x ULN",
"criterion": "SGOT/AST level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "x ULN"
}
}
]
},
{
"exact_snippets": "serum glutamate pyruvate transaminase (SGPT), alanine aminotransferase (ALT) =< 2.5 x ULN",
"criterion": "SGPT/ALT level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Total bilirubin < 2 x ULN for institution",
"criterions": [
{
"exact_snippets": "Total bilirubin < 2 x ULN for institution",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2,
"unit": "x ULN for institution"
}
}
]
}
]
},
{
"line": "* Alkaline phosphatase < 2 x the ULN",
"criterions": [
{
"exact_snippets": "Alkaline phosphatase < 2 x the ULN",
"criterion": "alkaline phosphatase",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2,
"unit": "x the ULN"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 50 Years",
"criterions": [
{
"exact_snippets": "minimum age of 50 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Completely resected",
"criterions": [
{
"exact_snippets": "Completely resected",
"criterion": "tumor",
"requirements": [
{
"requirement_type": "resection status",
"expected_value": "completely resected"
}
]
}
]
},
{
"line": "* Prior hormone or chemotherapy",
"criterions": [
{
"exact_snippets": "Prior hormone or chemotherapy",
"criterion": "prior treatment",
"requirements": [
{
"requirement_type": "types",
"expected_value": [
"hormone",
"chemotherapy"
]
}
]
}
]
},
{
"line": "* Unable to take oral medication",
"criterions": [
{
"exact_snippets": "Unable to take oral medication",
"criterion": "ability to take oral medication",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients who have nonmalignant systemic disease (cardiovascular, renal, hepatic, etc.) that would preclude their being subjected to protocol therapy",
"criterions": [
{
"exact_snippets": "nonmalignant systemic disease (cardiovascular, renal, hepatic, etc.)",
"criterion": "nonmalignant systemic disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "preclude their being subjected to protocol therapy",
"criterion": "ability to undergo protocol therapy",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}